Pollutant quartilea | PM2.5 (ug/m3) | O3 (ppb) | |||||
---|---|---|---|---|---|---|---|
Analytical strata | BI-RADS I OR (95% CI) | BI-RADS III OR (95% CI) | BI-RADS IV OR (95% CI) | BI-RADS I OR (95% CI) | BI-RADS III OR (95% CI) | BI-RADS IV OR (95% CI) | |
BMI <30b | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 1.01 (0.96–1.06) | 1.06 (1.03–1.09) | 0.88 (0.84–0.92) | 0.97 (0.90–1.04) | 1.15 (1.11–1.20) | 1.10 (1.04–1.16) | |
3rd | 0.93 (0.88–0.98) | 1.16 (1.13–1.20) | 0.98 (0.94–1.03) | 0.87 (0.79–0.96) | 1.14 (1.09–1.20) | 1.02 (0.94–1.10) | |
4th | 0.95 (0.90–1.01) | 1.16 (1.12–1.20) | 0.94 (0.89–0.99) | 1.12 (1.01–1.25) | 1.02 (0.96–1.07) | 0.85 (0.78–0.93) | |
BMI ≥30b | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.91 (0.86–0.95) | 1.16 (1.10–1.22) | 1.20 (1.02–1.41) | 0.78 (0.73–0.84) | 1.07 (1.01–1.12) | 1.03 (0.88–1.21) | |
3rd | 0.79 (0.75–0.84) | 1.27 (1.20–1.33) | 1.05 (0.89–1.24) | 0.84 (0.76–0.93) | 1.06 (0.97–1.15) | 0.94 (0.73–1.20) | |
4th | 0.85 (0.81–0.91) | 1.27 (1.20–1.34) | 1.09 (0.91–1.30) | 1.13 (1.02–1.25) | 0.93 (0.85–1.02) | 0.62 (0.46–0.82) | |
Premenopausalc | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.96 (0.87–1.06) | 1.06 (1.01–1.12) | 0.92 (0.85–0.99) | 0.85 (0.72–1.00) | 1.17 (1.09–1.26) | 1.16 (1.06–1.26) | |
3rd | 0.82 (0.74–0.91) | 1.25 (1.19–1.32) | 1.06 (0.98–1.15) | 0.82 (0.67–1.00) | 1.25 (1.14–1.37) | 1.16 (1.03–1.32) | |
4th | 0.86 (0.77–0.96) | 1.20 (1.13–1.26) | 0.97 (0.89–1.05) | 1.04 (0.84–1.28) | 1.21 (1.10–1.33) | 0.99 (0.86–1.13) | |
Postmenopausal/no HRTc | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.94 (0.91–0.98) | 1.08 (1.05–1.12) | 0.90 (0.84–0.97) | 0.85 (0.80–0.90) | 1.10 (1.06–1.14) | 1.06 (0.99–1.13) | |
3rd | 0.83 (0.79–0.87) | 1.15 (1.11–1.19) | 0.97 (0.90–1.04) | 0.83 (0.77–0.90) | 1.05 (0.99–1.11) | 0.87 (0.78–0.98) | |
4th | 0.88 (0.84–0.92) | 1.21 (1.17–1.25) | 1.01 (0.94–1.09) | 1.11 (1.02–1.21) | 0.88 (0.83–0.94) | 0.69 (0.61–0.79) | |
Postmenopausal/with HRTc | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.98 (0.87–1.10) | 1.14 (1.06–1.22) | 0.88 (0.77–1.00) | 0.90 (0.77–1.06) | 1.21 (1.12–1.30) | 1.04 (0.91–1.19) | |
3rd | 0.96 (0.84–1.09) | 1.29 (1.20–1.39) | 1.08 (0.95–1.24) | 0.86 (0.70–1.07) | 1.19 (1.06–1.33) | 1.08 (0.87–1.33) | |
4th | 1.00 (0.87–1.14) | 1.15 (1.06–1.24) | 0.96 (0.83–1.10) | 1.02 (0.81–1.30) | 1.03 (0.90–1.18) | 0.80 (0.62–1.03) | |
Perimenopausalc | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.97 (0.74–1.28) | 0.98 (0.83–1.15) | 0.93 (0.72–1.21) | 0.83 (0.54–1.27) | 0.94 (0.78–1.14) | 0.93 (0.70–1.23) | |
3rd | 1.06 (0.79–1.41) | 1.16 (0.98–1.37) | 1.03 (0.79–1.34) | 0.95 (0.54–1.65) | 0.89 (0.68–1.17) | 0.75 (0.48–1.16) | |
4th | 0.95 (0.69–1.30) | 1.34 (1.12–1.60) | 1.07 (0.80–1.42) | 1.29 (0.72–2.31) | 0.76 (0.56–1.03) | 0.62 (0.38–1.02) | |
No Family history of breast cancerd | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 0.93 (0.89–0.97) | 1.08 (1.05–1.12) | 0.90 (0.85–0.94) | 0.87 (0.82–0.92) | 1.12 (1.09–1.16) | 1.10 (1.04–1.16) | |
3rd | 0.83 (0.80–0.87) | 1.20 (1.16–1.23) | 1.00 (0.95–1.05) | 0.85 (0.79–0.92) | 1.11 (1.06–1.16) | 0.99 (0.91–1.07) | |
4th | 0.87 (0.83–0.91) | 1.21 (1.17–1.25) | 0.95 (0.90–1.01) | 1.11 (1.03–1.21) | 0.98 (0.93–1.03) | 0.80 (0.73–0.88) | |
Family history of breast cancerd | |||||||
1st | Referent | Referent | Referent | Referent | Referent | Referent | |
2nd | 1.05 (0.96–1.14) | 1.05 (0.99–1.12) | 0.92 (0.82–1.03) | 0.79 (0.70–0.90) | 1.15 (1.08–1.24) | 1.02 (0.90–1.14) | |
3rd | 0.90 (0.82–0.99) | 1.17 (1.10–1.24) | 0.99 (0.88–1.11) | 0.82 (0.69–0.98) | 1.15 (1.04–1.28) | 1.02 (0.85–1.22) | |
4th | 0.93 (0.84–1.03) | 1.12 (1.05–1.20) | 1.05 (0.94–1.18) | 1.13 (0.94–1.35) | 1.01 (0.90–1.13) | 0.77 (0.63–0.94) |